Regardless of their relationship with the patient, caregivers frequently make a profound commitment to their loved ones. They may sacrifice just as much, if not more, than the patient, and should be treated with the respect their participation deserves. synteract.com/NewsEvents/Blo…

eCOA is a big part of #DecentralizedTrials, and a big use of technology for all of clinical research. But there are some uses and limitations within the #RareDisease space. Learn more: vimeo.com/548022718

Loving this easy on the eyes, deep dive into the latest in #oncology for #ScienceSaturday. deep-dive.pharmaphorum.com/magazine/oncol…

As we come back into offices, your reactivation teams will have prepared SO many acknowledgments, reminders, and tips for how to conduct ourselves in a post-pandemic world. But these tips might help you navigate your first week back - on a personal level. medium.com/fast-company/d…

We have an exciting opportunity to join our QA leadership team! Start your #SynteractStrong journey by checking out the listing at synteract.com/careers, or click through to connect with Abz Ibrahim for more information! linkedin.com/posts/abz-ibra…

Although there are questions that remain with cell and gene therapies, they are undoubtedly going to continue to garner much focus and growth very rapidly over the next decade. Here's where we are now: synteract.com/NewsEvents/Blo…

Great perspective on how to actually put the patient first. deep-dive.pharmaphorum.com/magazine/marke…

The pandemic has affected much of how we conduct clinical research - including adjusting the way we conduct rater training in our #dermatology trials. vimeo.com/530469325

What happens when you're working with a sick patient and unexpectedly discover a new gene...with a fundamental role in regulating inflammation? Click through and find out. #ScienceSaturday news.yale.edu/2021/07/29/rar…

"Let's face it: It's not just a medical or scientific issue. It's a moral issue, too." - Scott Treiber, on how we can move the needle on diversity, equity and inclusion in #ClinicalTrials. #DEI #DiversityAndInclusion #ClinicalResearch vimeo.com/531044021

What a great update from Abz Ibrahim on some awesome opportunities that we have available on various teams. Start your #SynteractStrong journey by clicking through to Abz' original post to check out our latest openings! linkedin.com/posts/abz-ibra…

Instead of determining viability based on the number of available patients, some areas of investigation can help determine if a country is an option for your #raredisease trial, including patient protections and logistics and materials transfer. synteract.com/NewsEvents/Blo…

"What I've found over the years is that the most powerful way to combat anxiety is to consistently work on building your resilience and mental strength." Some helpful #ScienceSaturday exercises for you. www-cnbc-com.cdn.ampproject.org/c/s/www.cnbc.c…

Pleased to stand with Association of Clinical Research Organizations (ACRO) and Syneos Health on this incredibly important issue. bit.ly/3neTvf1 #SyneosHealth #vaccine linkedin.com/posts/syneos-h…

Feels like we've all had to flex into some version of intro-, extro-, ambi- vert over the last 550 days of virtual meetings. But these tips might help some of your meetings this coming week, maybe? Feel free to drop your own tips below! forbes.com/sites/juliawue…

We've moved! For the latest news, follow us at Syneos Health!

Synteract is now a part of Syneos Health. With 30+ years of experience working side by side with biotech companies – in nearly every therapeutic category and across the product development continuum – Syneos Health is uniquely positioned to address ever-evolving biotech dynamics.

Synteract is now a part of Syneos Health. With 30+ years of experience working side by side with biotech companies – in nearly every therapeutic category and across the product development continuum – Syneos Health is uniquely positioned to address ever-evolving biotech dynamics.